Kang-Yell Choi

Kang-Yell Choi

Chief Executive Officer @ CK Regeon

About

Dr. Kang-Yell Choi is a professor of Biotechnology in Yonsei University and have a joint appointment position as a CEO of CK Regeon Inc., Seoul, Korea. Dr. Choi was awarded his Ph.D. at Purdue University in 1993 and finished a postdoctoral training at Harvard Medical School. As initiated his research as an assistant professor in 1995, he has been performed research related with cellular signaling especially for the Wnt/β -catenin pathway involving various pathophysiologies. For last 10 years, he led the Translational Research Center for Protein Function Control (TRCP/ERC), a Korean government supported drug development institute, as a director. Dr. Choi has been carrying out R&D to develop agents controlling cancer as well as hair-loss, wound healing, and anti-aging etc. Currently, he is interested in the development of safe agents inducing regeneration of tissues via activation of the Wnt/-catenin signaling, not by direct activation but by release negative feedback mechanism. He found that CXXC5, a negative feedback regulator of Wnt/b-catenin pathway which function via interaction with Disheveled (Dvl) at cytosol, is overexpressed in tissues of the bald scalp and aged skins. Dr. Choi demonstrated the” CXXC5-Dvl protein-protein interaction (PPI)” as a target for development of agents enhancing wound healing and hair neogenesis by developing a PTD-DBM, a peptide recovers the suppressed Wnt/b-catenin signaling via blockade of the CXXC5-Dvl PPI. By topical application, the PTD-DBM peptide, especially when co-treated with a Wnt/β -catenin signaling activator such as valproic acid, induced neogenic hair growth and enhanced wound healing process. The PTD-DBM peptide is also revealed effective anti-aging effect of skin as shown by critical increment of collagen production with cell migration as well as its effects on suppression of ROS generation and apoptosis of skin cells in the tissues induced aging. The PTD-DBM peptide popularly has been used as agents for treatment of hair loss in North America. Based on the drug development experience and research outcomes, Dr. Choi established CK Regeon in 2016 and has been executing R&D in developing First-in-Class multi-pipeline small molecule drugs for obesity, diabetes, NASH, Alzheimer’s disease as well as hair-loss, wound healing, etc.

Country

South Korea

City

Seoul

Industry

Biotechnology

Skill

-

Experience

CK Regeon

Chief Executive Officer

CK Regeon

LinkedIn
2016-10 - Present · 10 yrs

Seoul, South Korea

Company Website http://ckregeon.com/

Yonsei University

Professor, Department of Biotechnology, College of Life Sciences and Biotechnology

Yonsei University

LinkedIn
2004 - Present · 22 yrs

Seoul, South Korea

Yonsei University

Head, Cooperative Genome Program

Yonsei University

LinkedIn
2006 - 2007 · 1 yr

Seoul, South Korea

Yonsei University

Associate Professor, College of Life Sciences and Biotechnology

Yonsei University

LinkedIn
2001 - 2004 · 3 yrs

Seoul, South Korea

Yonsei University

Assistant/Associate Professor, Department of Biochemistry-Molecular Biology, College of Medicine

Yonsei University

LinkedIn
1995 - 2001 · 6 yrs

Seoul, South Korea

Korea Drug Development Fund (KDDF)

Evaluation & Investment Committee Members

Korea Drug Development Fund (KDDF)

2013 - 2019 · 6 yrs

Seoul, South Korea

Translational Research Center for Protein Function Control (TRCP/ERC)

Director

Translational Research Center for Protein Function Control (TRCP/ERC)

2009 - 2019 · 10 yrs

Seoul, South Korea

National Research Laboratory (NRL)

National Research Laboratory (NRL)

National Research Laboratory (NRL)

2005 - 2019 · 14 yrs

Seoul, South Korea

Harvard Medical School

Postdoctoral Fellow

Harvard Medical School

1993 - 1995 · 2 yrs

Boston, Massachusetts, United States

Education

Harvard Medical School

Harvard Medical School

LinkedIn

Biochemistry & Molecular Pharmacology

1993 - 1995 · 2 yrs
Purdue University

Purdue University

LinkedIn

Biochemistry

1989 - 1992 · 3 yrs
Yonsei University

Yonsei University

LinkedIn

Biotechnology

1978 - 1984 · 6 yrs

Kang-Yell Choi's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.